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Received January 9, 2014; accepted May 17, 2014AbstractBackground: The analgesic effect of xylocaine alone versus xylocaine with corticosteroid injection after ultrasonographically (US)-guided
treatment of rotator cuff calcific tendonosis has not been described in English literature. The aim of this study was to compare the analgesic
effect of xylocaine only with xylocaine and corticosteroid following US-guided percutaneous treatment of rotator cuff calcific tendonosis.
Methods: This prospective study enrolled 88 patients who were given different analgesic treatments [xylocaine only, n ¼ 23; xylocaine with
corticosteroid, n ¼ 44; control (no xylocaine or corticosteroid), n ¼ 21]. The assessment of a patient's painful symptoms was recorded before
treatment, and 1 day, 1 week, 1 month and 3 months after treatment using the visual analogue scale (VAS).
Results: There were no significant differences in age, sex, calcification size before and after treatment, and amount of calcification decrease after
treatment, but there was a significant difference in calcification morphology among the groups ( p ¼ 0.010). General linear model analysis
indicated that the three groups had no difference in pain prior to treatment. After treatment, the xylocaine only and the xylocaine with corti-
costeroid groups had less pain than the control group at 1 day, 1 week, and 1 month after treatment. At 3 months after treatment, the xylocaine
only group had less pain than the control group ( p ¼ 0.039), and the xylocaine with corticosteroid and control groups had similar levels of pain.
Conclusion: Injection of xylocaine alone after US-guided treatment of rotator cuff calcific tendonosis provided a longer pain relief period than
that of a mixture of xylocaine with corticosteroid.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Calcific tendonosis of the rotator cuff is a common disorder,
especially in the supraspinatus tendon,1 and usually causesConflicts of interest: The authors declare that there are no conflicts of interest
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1726-4901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Assinflammation and pain in the shoulder region. The pathogen-
esis of rotator cuff calcification is uncertain, but it may be due
to ischemia2 or degeneration3 leading to fibrocartilaginous
metaplasia and ultimately calcification.4,5 Previous research
reported that chronic and acute calcific tendonosis were
mostly caused by the deposition of hydroxyapatite (HAP) in
the periarticular tendon.6
Diverse methods can be used to manage rotator cuff calcific
tendonosis. Conservative treatments include physical therapy
with a short course of an oral nonsteroidal antiinflammatoryociation. All rights reserved.
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fluoroscopic procedure,9,10 extracorporeal shock wave
therapy,1e12 or single or two-needle ultrasonographically
(US)-guided techniques.13e19 Although there is no proven
advantage of single or two-needle US-guided techniques, there
is potential for tendon damage from use of multiple needles or
a large needle. Previous studies indicated that US-guided fine-
needle repeated puncture was an effective method for treat-
ment of rotator cuff calcific tendonosis.17,19
Although the US-guided technique is effective for manage-
ment of calcific tendonosis, most patients complain of severe
pain for 1 week or more after this procedure. Fortunately, this
pain can often be resolved by use of analgesic drugs and
corticosteroid injection into the subdeltoid bursa.13e19 Never-
theless, the analgesic effect of xylocaine alone versus xylocaine
and corticosteroid injection has not been described in English
literature. The US-guided fine-needle repeated puncture treat-
ment creates an iatrogenic inflammatory process, which is
necessary for effective resorption of calcium HAP following
treatment of calcific tendonosis. The additional corticosteroid
could potentially compromise the inflammatory process.
The purpose of this study is to compare the analgesic effect
of xylocaine alone with xylocaine and corticosteroid injection
of the subdeltoid bursa after a US-guided procedure for
management of calcific tendonosis.
2. Methods2.1. ParticipantsThis was a prospective study that enrolled consecutive
outpatients at the department of orthopedics or patients in
rehabilitation due to chronic shoulder pain for >6 months. The
primary inclusion criterion was the presence of calcifications
within the rotator cuff with confirmation by gray-scale US. All
patients who had previous invasive treatment for calcifications
within the rotator cuff, including lithotripsy, arthroscopy or
other imaging-guided procedures, and extracorporeal shock
wave therapy were excluded. In addition, patients who had
corticosteroid injections in the previous 6 months or
concomitant rotator cuff tear were excluded. A total of 88
participants (29 men and 59 women; mean age: 57.9 years;
age range: 32e83 years) who received US-guided repeated
puncture for calcifications were enrolled from October 2009 to
December 2011. All participants provided written informed
consent for US-guided treatment of rotator cuff calcific ten-
donosis. Investigative and interventional procedures were
performed according to the guidelines of the Helsinki Decla-
ration and were approved by an institutional review board in
Taipei Veterans General Hospital.2.2. Pain assessmentThe clinical assessment employed a visual analogue scale
(VAS), in which each patient graded his/her own symptoms
from 0 (painless) to 10 (the most painful sensation). Pain
assessment was performed before treatment, and 1 day, 1week, 1 month and 3 months after treatment by telephone
query from a clinical assistant who was blinded to the treat-
ments of all patients.2.3. US-guided technique for treatment of rotator cuff
calcific tendonosisThe morphology of the calcification, based on high-
resolution US (HRUS), was classified as an arc, fragmented,
nodular, or cystic16,17 and the longest diameter of the calcifi-
cation was recorded. Prior to use of the US-guided technique,
each patient was given the opportunity to receive treatment
with xylocaine alone, or treatment with xylocaine and corti-
costeroid, or no analgesic drug (control group). Patients in the
xylocaine group were given 2 mL of 2% xylocaine (Reci-
pharm Monts, Monts, France) and patients in the xylocaine
with corticosteroid group were given 1 mL of 2% xylocaine
mixed with 1 mL of corticosteroid (10 mg triamcinolone
acetonide, Shincort, Yung Shin Pharmaceutical Industrial
Company, Taichung, Taiwan). All injections were into the
subdeltoid bursa with US guidance. If a patient did not want to
choose or did not know how to choose a treatment group, a
coin toss was used to determine group assignment.
The puncture procedure was performed with a US-
monitored free-hand method. The needle tip was placed in
the calcification, which was then punctured by moving the
needle back and forth. There was no large-needle lavage in
this study. The puncture needle was a 3.8 cm 21 gauge needle
attached on a 10 mL syringe. Prior to the procedure, the skin
of the puncture site was sterilized with beta iodine, and the
transducer was covered with a sterilized plastic bag. Less than
2 mL of 2% xylocaine was injected in the subcutaneous and
muscle layer. The US-guided repeated punctures were per-
formed by moving the needle back-and-forth 20e40 times,
according to the size and other characteristics of the calcifi-
cations, without removing the needle from the initial puncture
site. The needle tract was monitored by HRUS to ensure that
it had penetrated the calcification. After this procedure,
analgesia (xylocaine or xylocaine with corticosteroid) was
injected into the subdeltoid bursa. The puncture site was
bandaged with self-administered hand compression for 15
minutes. All patients were sent home and encouraged to
actively exercise the affected shoulder starting the next
day.16,17 All US examinations and US-guided treatments were
performed by one of the authors (H.J.C.) who has >20 years
of experience in US and 15 years of experience in musculo-
skeletal US.
Each participant's symptoms were recorded before treat-
ment, and 1 day, 1 week, 1 month and 3 months after treatment
by telephone query from a clinical assistant who was blinded
to the treatment. All patients also returned for follow-up US
examinations by the same author (H.J.C.) at 6 months after
treatment.
The US machines were the GE Voluson E8 system (GE
Medical Systems, Milwaukee, WI, USA) with the SP 10-16-D
linear transducer, the Philips iU 22 system (Philips-ATL,
Bothell, WA, USA) with the L12-5 linear transducer, and the
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with the 14L5 linear transducer.2.4. Statistical analysisThe Chi-square test or Fisher's exact test was used to assess
differences in sex and type of calcification, and a one-way
analysis of variance was used to assess differences in patient
age, calcification size, and VAS scores at different times. A
general linear model was used to assess differences in pre- and
posttreatment VAS values. A p value <0.05 was considered
significant and all statistical analyses were performed with
SPSS version 17 for Windows (SPSS Inc., Chicago, IL, USA).
3. Results
A total of 23 patients received 2 mL of xylocaine only, 44
patients received 1 mL of xylocaine mixed with 1 mL of
corticosteroid, and 21 patients received no analgesic. There
were no significant differences among these groups in age
( p ¼ 0.696), sex ( p ¼ 0.698), calcification size before treat-
ment ( p ¼ 0.245), calcification size after treatment
( p ¼ 0.970), and change in calcification size ( p ¼ 0.900)
(Table 1). However, there was a significant difference in
calcific morphology among the three groups ( p ¼ 0.020). Arc
type of calcification was most common in the control group,
nodular type of calcification was most common in the xylo-
caine only group, and arc type of calcification was most
common in the xylocaine with corticosteroid group.
In the xylocaine-only group, the mean VAS pain declined
from 6.35 to 0.65 at 3 months after treatment, and the mean
size of the calcification declined from 1.00 cm to 0.3 cm at 6
months after treatment. Fig. 1 shows a representative patient
from this group. In the xylocaine with corticosteroid group, theTable 1
Demographic data.









Age (y) 55.8 ± 7.10 59.
Size of calcification (cm)
Before treatment 1.00 ± 0.52 0.9
6 mo after treatment 0.30 ± 0.39 0.2
Decreasing % of calcification 71.5 ± 28.1 67.
Visual analogue scale
Before treatment 6.35 ± 2.62 6.1
1 d after treatment 3.22 ± 2.35 2.6
1 wk after treatment 1.83 ± 1.67 1.6
1 mo after treatment 1.52 ± 1.59 2.1
3 mo after treatment 0.65 ± 1.03 1.9
Data are presented as mean ± standard deviation.mean VAS pain declined from 6.18 to 1.98 at 3 months after
treatment and the mean size of the calcification declined from
0.92 cm to 0.28 cm at 6 months after treatment. Fig. 2 shows a
representative patient from this group. In the control group, the
mean VAS pain declined from 5.14 to 1.81 at 3 months after
treatment and the mean size of the calcification declined from
1.02 cm to 0.29 cm at 6 months after treatment. Among the
three groups, there was no significant difference in VAS pain
before treatment ( p ¼ 0.194), but the VAS pain 1 day
( p < 0.001), 1 week ( p < 0.001), 1 month ( p ¼ 0.017) and 3
months ( p ¼ 0.019) after treatment was significantly lower in
the xylocaine-only group and in the xylocaine with cortico-
steroid group relative to the control group (Table 1). None of
the patients experienced complications, such as bleeding,
infection, or ligament tear.
Finally, we used general linear model analysis to compare
the levels of VAS pain in the three groups at different times
after treatment. The results indicate no significant difference in
pain before treatment, but significantly less pain in the
xylocaine-only and the xylocaine with corticosteroid groups
relative to the control group at 1 day, 1 week, and 1 month
after treatment (Table 2). At 3 months after treatment, VAS
pain in the xylocaine only group was significantly less than
that in the control group ( p ¼ 0.039), but VAS pain in the
xylocaine with corticosteroid group was not significantly
different from that in the control group ( p ¼ 0.730). The same
results were found after controlling for type of calcification
(data not shown).
4. Discussion
The US-guided procedure used to treat calcific tendonosis
introduces iatrogenic minor trauma over the calcification,







6 ± 10.8 56.8 ± 13.1 0.696
2 ± 0.42 1.02 ± 0.64 0.245
8 ± 0.29 0.29 ± 0.26 0.970
9 ± 30.6 68.0 ± 16.7 0.900
8 ± 2.52 5.14 ± 1.93 0.194
1 ± 2.07 6.67 ± 1.65 <0.001
8 ± 1.52 6.10 ± 1.76 <0.001
4 ± 1.95 3.10 ± 1.67 0.017
8 ± 2.34 1.81 ± 1.12 0.019
Fig. 1. A 45-year-old female patient complained of right shoulder pain for >1 year. Ultrasonography showed an arc-shaped calcification in the right supraspinatus
tendon (arrowheads in A). After ultrasonography (US)-guided repeated puncture, 2 mL of xylocaine was injected into the right subdeltoid bursa (arrowheads in B).
Six months later, ultrasonography showed only tiny calcification spots (arrowheads in C), and the patient reported marked reduction of pain.
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the US-guided technique is effective for management of
calcific tendonosis,13e18 most patients complain of severe pain
for >1 week after the procedure. Fortunately, this pain can be
managed by use of analgesic drugs or corticosteroid injections
into the subdeltoid bursa. In this study, we found that the
percent decrease in calcifications after surgery was similar for
patients in the xylocaine, xylocaine with corticosteroid, and
control groups. Thus, these analgesics appeared to have no
effect on the resorption of calcifications. However, patients in
the xylocaine only group had less pain at 3 months after sur-
gery than those in the xylocaine with corticosteroid group and
in the control group.
Corticosteroid injection can relieve the shoulder pain
associated with diverse musculoskeletal conditions.20e26
These drugs have antiinflammatory effects, inhibit the syn-
thesis of glycosaminoglycans, proteins, and collagen,27 and
alter fibroblast proliferation and metabolism.28 However,
these later effects may be classified as antianabolic, so corti-
costeroids may also have adverse effects on wound and soft
tissue healing.29,30 Thus, the short term use of an analgesic
such as xylocaine is often recommended for relief of shoulder
pain in order to prevent the adverse effects of corticosteroids
in soft tissue.21,23e26 Xylocaine is generally used as a local
analgesic and is injected into subcutaneous, intramuscular, or
intrabursal regions. Although xylocaine is also associated with
some adverse cardiovascular and neurological effects, thesetypically only occur following large doses or intravascular
injections.
Xylocaine only provides short-term relief from pain, so it
may be combined with a corticosteroid in order to provide
prolonged pain relief. In particular, xylocaine provides short-
term pain relief due to its effect as a local anesthetic (inhibi-
tion of neuronal ion fluxes), but corticosteroids provide long-
term relief from pain due to their long-term effects on
diverse types of cells and endogenous molecules involved in
inflammation.31,32 The US-guided fine-needle repeated punc-
ture treatment creates an iatrogenic inflammatory process,
which is necessary for effective resorption of calcium HAP
following treatment of calcific tendonosis. Our results indicate
that the xylocaine only and the xylocaine with corticosteroid
groups had similarly reduced levels of pain relative to the
control group for up to 1 month after US-guided treatment for
calcific tendonosis. However, the xylocaine only group had
less pain than the xylocaine with corticosteroid group at 3
months after treatment. Corticosteroid injections are believed
to compromise the inflammatory process and inhibit the
resorption of calcifications following percutaneous treatment
of rotator cuff calcific tendonosis.
Our study had several limitations. First, participants were
not randomized and this could have led to selection bias.
Second, all patients were treated by US-guided repeated
punctures, and single or double lavage techniques, which are
common in some institutions, were not performed. Third, the
Fig. 2. A 41-year-old female complained of right shoulder pain for 1 year. Ultrasonography showed a nodular calcification in the right supraspinatus tendon
(arrowheads in A). After ultrasonography (US)-guided repeated puncture, 1 mL of xylocaine with 1 mL of corticosteroid was injected into the right subdeltoid
bursa (arrowheads in B). Six months later, ultrasonography showed a cluster of punctate calcification spots, with >50% reduction in calcification (arrowheads in C),
and the patient reported marked reduction of pain.
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was 6 months for assessment of calcific morphology. It would
have been better to perform a final pain assessment at 6
months. In our institute, US-guided treatment of rotator cuffTable 2
General linear model analysis for visual analogue scale at different time
frames.






Xylocaine only 1.21 0.73 0.103 0.25~2.66
Xylocaine/corticosteroid 1.04 0.64 0.109 0.24~2.32
Control Reference
One day after treatment
Xylocaine only 3.45 0.62 <0.001 4.69~2.21
Xylocaine/corticosteroid 4.05 0.55 <0.001 5.14~2.97
Control Reference
One week after treatment
Xylocaine only 4.27 0.49 <0.001 5.24~3.30
Xylocaine/corticosteroid 4.41 0.43 <0.001 5.27~3.56
Control Reference
One month after treatment
Xylocaine only 1.57 0.54 0.005 2.65~0.50
Xylocaine/corticosteroid 0.96 0.48 0.048 1.91~0.01
Control Reference
Three months after treatment
Xylocaine only 1.16 0.55 0.039 2.25~0.06
Xylocaine/corticosteroid 0.17 0.48 0.730 0.80~1.13
Control Reference
CI ¼ confidence interval.tendonosis is routinely performed 6 months after treatment.
Fourth, we only examined the effect of a single corticosteroid
dose of 10 mg. However, our results showed a clear difference
between the xylocaine only and the xylocaine with cortico-
steroid groups compared to the control group from 1 day to 1
month after surgery.
In conclusion, patients who received US-guided percuta-
neous treatment for rotator cuff calcific tendonosis and were
given a xylocaine injection experienced less pain at 3 months
than those given a xylocaine and corticosteroid injection. In-
jection of xylocaine alone appears to provide effective relief
from the shoulder pain associated with US-guided repeated
punctures for treatment of rotator cuff calcific tendonosis.
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